SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (11853)7/21/1998 6:08:00 PM
From: VLAD  Read Replies (1) of 23519
 
martin,

I agree with all that you say but I am getting "worn out" waiting for a turn around. Although I know that earnings will be good from now on, I would just rather see an immediate buy-out so that I can cash in my chips and play a different game.

It seems to me that Vivus may not be able to wait for Q3 earnings to command a higher stock price in a buy out. If they know what is good for them then they simply need to sell out and take a lower price.

Vivus is currently strapped for cash. I think that present earnings and cost reductions will allow for a positive cash flow but I think they could potentially do a lot more and expand their drug pipeline for their intraurethral delivery system if they just sell out to deeper pockets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext